The 19 analysts offering 12-month price forecasts for Abbvie Inc have a median target of 129.00, with a high estimate of 148.00 and a low estimate of 105.00. The median estimate represents a +19.72% increase from the last price of 107.75.
The current consensus among 21 polled investment analysts is to Buy stock in Abbvie Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $3.23
Reporting Date Oct 29
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.